SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000909518-08-000337
Filing Date
2008-04-11
Accepted
2008-04-11 17:21:12
Documents
1
Group Members
EXPLORER ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 mm04-1108_13d.txt SC 13D 48009
  Complete submission text file 0000909518-08-000337.txt   50257
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Subject) CIK: 0000887023 (see all company filings)

IRS No.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44359 | Film No.: 08753031
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1